Results come after positive results from a trial among people with idiopathic pulmomary disease.

Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood ...

Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...

Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, ...

Pliant Therapeutics has terminated its idiopathic pulmonary fibrosis (IPF) program after digging into the increased rate of ...

Chinese scientists have developed a novel nanotherapy known as biomimetic extracellular vesicle spherical nucleic acids ...

Puretech Health plc’s rollout May 20 of more phase IIb data with deupirfenidone (LYT-100) in idiopathic pulmonary fibrosis ...

Pulmonary rehabilitation is initiated and completed by a greater proportion of patients with IPF vs COPD or other chronic respiratory disorders.

Get Instant Summarized Text (Gist) An FDA-approved cancer drug that blocks the CTLA4 protein enabled immune cells to clear senescent cells in a mouse model of idiopathic pulmonary fibrosis (IPF ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...